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Abstract 
Objective: To determine the causative agents of infections and their antimicrobial susceptibility at a ter-
tiary care hospital in Moshi, Tanzania, to guide optimal treatment. 
Methods: A total of 590 specimens (stool (56), sputum (122), blood (126) and wound swabs (286)) were 
collected from 575 patients admitted in the medical and surgical departments. The bacterial species were 
determined by conventional methods and disk diffusion was used to determine the antimicrobial suscepti-
bility pattern of the bacteria isolates. 
Results: A total of 249 (42.2%) specimens were culture-positive yielding a total of 377 isolates. A wide 
range of bacteria was isolated, the most predominant being Gram-negative bacteria: Proteus spp. (n=48, 
12.7%), Escherichia coli (n=44, 11.7%), Pseudomonas spp. (n=40, 10.6%), and Klebsiella spp (n=38, 10.1%). 
Wound infections were characterised by multiple isolates (n=293, 77.7%), with the most frequent being 
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Proteus spp. (n=44, 15%), Pseudomonas (n=37, 12.6%), Staphylococcus (n=29, 9.9%), and Klebsiella spp. 
(n=28, 9.6%). All S. aureus tested were resistant to penicillin (n=22, 100%) and susceptible to vancomycin. 
Significant resistance to cephalosporins such as cefazoline (n=62, 72.9%), ceftriaxone (n=44, 51.8%) and 
ceftazidime (n=40, 37.4%) was observed in Gram-negative bacteria; as well as resistance to cefoxitin (n=6, 
27.3%) in Staphylococcus aureus.  
Conclusion: The study has revealed a wide range of causative agents, with an alarming rate of resistance to 
the commonly used antimicrobial agents. Furthermore, the bacterial spectrum differs from those often ob-
served in high-income countries. This highlights the imperative of regular generation of data on aetiological 
agents and their antimicrobial susceptibility patterns especially in infectious disease endemic settings. The 
key steps would be to ensure the diagnostic capacity at a sufficient number of sites and implement struc-
tures to routinely exchange, compare, analyse and report data. Sentinel sites (hospitals) across the country 
(and region) should report on a representative subset of bacterial species and their susceptibility to drugs 
at least annually. A central organizing body should collate the data and report to relevant national and in-
ternational stakeholders. 
 
Keywords: Bacterial infections; antimicrobial resistance; Africa; Western Europe; America 
 
Introduction 
Regular review of patterns of infections and their antibacteriogram is key for empirical treatment, which is 
common in resource-poor settings. Over the past 20 years the pattern of infections and their susceptibility 
to antimicrobial agents1,2 has changed, likely due to factors such as increased use of antimicrobial agents3 
and rising prevalence of diabetes mellitus4 which due to socio-demographic changes5 is becoming a com-
mon comorbid condition for patients admitted due to infection6. Human immunodeficiency virus (HIV) has 
also changed the pattern of infections2; antiretroviral (ARV) therapies, which boost the immune status of 
the patients infected with HIV7, may play a role in the susceptibility to both common and opportunistic in-
fections8, as well as other chronic conditions such as cancer and kidney disease. 
 In Africa, infectious diseases constitute a much higher burden in people of all age groups 9–14 than in 
Europe and North America. Active surveillance systems on infectious disease control are inadequate in 
most African countries15–18, and the absence of data on disease causes and the lack of control measures add 
to the disease burden7. Obtaining adequate and timely data on infectious diseases in African countries is 
difficult, whereas much more data are available from developed countries. As a result empirical treatment 
in Africa regarding pathogenic bacteria might be based on data from clinical laboratories in developed 
countries19. The pattern of bacterial infections in Africa differs from those observed in Western Europe and 
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North America, hence empirical treatment should be adjusted to fit the different need. In Africa, as else-
where, regular local data collection about patterns of infections, and their response to antimicrobial 
agents, coupled with a long-term commitment to providing adequate health information systems, is key to 
effective planning and policy formulation. The availability of data on disease patterns, etiological agents 
and their antimicrobial resistance is a prerequisite for the establishment of empirical treatment regimens 
and for avoiding escalation of the global trend of bacterial resistance to the current antimicrobial regi-
mens20–22.  
 This study was conducted to determine the most frequent bacterial species isolated from samples 
submitted for microbiological examinations at a tertiary care hospital in Moshi, Tanzania. We also deter-
mined antimicrobial susceptibility patterns of the isolates and associated comorbid conditions. 
 
Materials and methods 
Study design, location and sample collection 
This study is a descriptive analysis of culture, bacterial identification and antimicrobial susceptibility testing 
conducted at Kilimanjaro Christian Medical Centre (KCMC), which hosts a tertiary health care facility for the 
northern zone of Tanzania. The study was conducted from August 2013 to August 2015. Clinical samples 
were collected from inpatients admitted to the medical or surgical wards of the hospital. Informed consent 
was obtained from all participants. Specimens including stool (56), sputum (122), blood (56) and 
wound/pus swabs (286) were collected from 575 patients. Twenty specimens were not included due to in-
sufficient quantity. Blood, stool, or sputum samples were collected if the patient was diagnosed to have 
septicemia, diarrhoea, or upper respiratory infection, respectively. Blood samples were also collected from 
patients with fever of unknown cause. Wound or pus swabs were collected from wounds due to burns, sur-
gical procedures, diabetes mellitus, animal bites, motor traffic accidents and other injuries. 
 Patient hospital files were used to obtain socio-demographics and clinical characteristics of the study 
participants admitted at KCMC wards. Data were recorded on designated case report forms (CRFs). All 
samples were transported immediately after collection to the Kilimanjaro Clinical Research Institute (KCRI), 
to be processed by the microbiology unit of the biotechnology laboratory department. 
 
Culture and identification  
Wound/pus swabs and sputum specimens were cultured onto Trypticase Soy Agar with 5% Sheep Blood 
(BD BBL™), chocolate agar and McConkey agar plate media (BD BBL™) and incubated at 37 °C with 5% CO2 
for 18-24 hours. Stool samples were cultured onto McConkey agar and incubated at 37 °C overnight. Blood 
samples were collected in 40 mL BD BACTEC standard 10 Aerobic/F, followed by incubation in BD BACTEC 
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for a maximum of 5 days. Gram stain was used to differentiate gram positive and negative bacteria from 
culture. Positive blood cultures were inoculated on blood agar, chocolate agar and McConkey agar and in-
cubated for 18-24 hours at 37 °C with 5% CO2. Bacteria were isolated from culture by picking single colonies 
and subculturing onto purity plate (Blood agar) overnight. From the purity plate, morphology determina-
tion and gram stain was done followed by microscopic examination. 
 Based on Gram staining results, Gram-negative bacteria were identified using API 20E and/or API NE 20 
(bioMérieux) for Enterobacteriacae and other non-fastidious Gram-negatives. Catalase and coagulase tests 
were used to identify Gram-positive cocci. Optochin susceptibility testing (BD BBL TaxoTM. Benex Limited, 
Shannon County Clare, Ireland) was used to confirm Streptococcus pneumoniae, and BD BBL Streptocard ® 
Enzyme Latex test was used to identify streptococcal group A, B, C, D, F and G.  
   
Antimicrobial susceptibility testing  
Antimicrobial susceptibility testing (AST) was done using disk diffusion on Müller Hinton II Agar (MHA) ac-
cording to Clinical Laboratory Standards Institute (CLSI, 2013) guidelines. Gram negative bacterial isolates 
were tested for ampicillin 10 μg, amox-clavulanic acid 30 μg, cefazoline 30 μg, ceftazidime 30 μg, ceftriaxon 
30 μg, chloramphenicol 30 μg, ciprofloxacin 5 μg, gentamicin 10 μg, nalidixic acid 30 μg and trimethoprim-
sulfamethoxazole 23.75 μg/1.25 μg. Antimicrobials tested for Gram-positive bacterial isolates were chlo-
ramphenicol, trimethoprim-sulfamethoxazole (23.75 μg/1.25 μg), erythromycin 15 μg, vancomycin 30 μg, 
penicillin 10 μg, and cefoxitin 30 μg. Interpretation as susceptible, intermediate resistant and resistant was 
done according to CLSI 2013. Isolates with intermediate or resistant results were merged into a single 
group as resistant during data analysis. Considering intermediate group as resistance can be one of the 
ways of sidestepping uncertain therapeutic effects23. 
 
Data analysis 
Data were double-entered in OpenClinica (OpenClinica LLC, Waltham MA, USA). Data extracts were export-
ed to STATA 13 (StataCorp LP, Texas 77845 USA). This tool was used for all analyses. Proportions of comor-
bidities and bacteria isolates were calculated and presented as column or row percentages.   
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Results 
Characteristics of the study participants   
Table 1 summarizes characteristics of 575 patients with different medical conditions enrolled in the study 
from August 2013 to August 2015. Five patients were excluded during analysis due to incomplete patient 
information. The median age (IQR) was 43 (30-57) years. 61% (n=348) were males, 39% females (n=227).  
 Half of the participants were peasants (n=271, 47.3%), the predominant education level was primary 
education (n=339, 59%); few participants (n=34, 5.9%) had tertiary education. 71.9% participants (n=412) 
had a history of receiving antibiotic treatment prior to admission. 45.9% of patients were admitted due to 
wound infection (n=263), 14.4% due to pneumonia (n=81), 10.5% due to tuberculosis (n=60), 8.03 % due to 
septicemia (n=46), 3.5% due to diarrhoea (n=20) and 0.7% due to meningitis (n=4). Coexisting health condi-
tions were diabetes mellitus (n=122, 21.3%), HIV (n=81, 14.1%), and cancer (n=52, 9.1%).  
 
Culture results 
A total of 590 specimens were cultured: 286 wound swabs, 126 blood, 122 sputum, and 56 stool samples. 
42.2% of the cultured specimens had positive growth after overnight incubation: 72.3% of wound swabs 
(n=180), 14.1% of sputum samples (n=35), 7.6% of stools (n=19), and 6% of blood samples (n=15).  
 We obtained 377 bacterial isolates. 43.8%) of specimens (n=109) had more than one isolate. 77.7% of 
isolates (n=293) were obtained from wound swabs, 11% (n=4), from sputum, 6.1% (n=23) from stools, and 
4.2% (n=16) from blood cultures (Table 2).  
 There was a wide range of bacterial isolates, the majority being Gram negative isolates, with Proteus 
spp (n=48, 12.7%), E. coli (n=44, 11.7%), Pseudomonas spp (n=40, 10.6%), and Klebsiella spp (n=38, 10.1%) 
being predominant, together accounting for 170 (45.1%) of all isolates. The Gram-positive bacteria were 
Staphylococcus aureus (n=35, 9.3%), coagulase negative Staphylococcus spp (n=25, 6.6%) and Streptococcus 
spp (n=17, 4.5%). Wound infections were characterised by multiple isolates (n=293, 77.7%), with the most 
frequent being Proteus spp (n=44, 15%), Pseudomonas (n=37, 12.6%), Staphylococcus (n=29, 9.9%), and 
Klebsiella spp (n=28, 9.6%). Streptococcus spp were the most common finding (n=9, 20%) in sputum sam-
ples, followed by Klebsiella spp (n=7, 15.6%). E.coli (n=11, 47.8%) was the predominant isolate in stool 
samples (Table 2). 
 
Pattern of infections and aetiological agents  
Table 3 outlines disease conditions found: wound infection (n=277, 45.8%), pneumonia (n=87, 14.4%), tu-
berculosis (n=64, 10.6%), septicemia (n=52, 8.6%), diarrhea (n=21, 3.5%) and %), and meningitis (n=4, 
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0.7%). S.aureus, Klebsiella spp, Proteus spp, E.coli and Pseudomonas spp were the most common bacterial 
pathogens isolated from patients with the above disease presentations. The distribution of these patho-
gens was diversified in wound infections. Septic wounds were dominated by Pseudomonas spp (n=31, 
77.5%), Proteus spp (n=37, 75.5%), E.coli (n= 24, 54.5%), S.aureus (n=20, 57.1%) and Klebsiella spp (n= 21, 
51.2%). Burn and diabetic wounds had more Proteus spp (n=10 (20.4%) and n=15 (30.6%), respectively). 
Motor traffic and post-surgical wounds had few bacterial isolates.  
 Tables 4a and b summarize the association between co-existing health conditions such as diabetes, 
cancer and HIV and the burden of commonly isolated bacteria. The prevalence of Proteus spp, Escherichia 
coli, and Pseudomonas spp infections was higher among people with diabetes and cancer, although the as-
sociations were not statistically significant (P>0.05). A statistically significant independent association was 
observed between the prevalence of Pseudomonas spp among HIV-negative patients (11%) and HIV-
positive patients (3%) (P=0.03). The prevalence of both Proteus spp (16%) and Pseudomonas spp (13%) 
among patients with wound infection was higher than in patients without (P=0.03). 
 
Pattern of resistance to antimicrobial agents 
About three-quarters of the patients (n=412, 71.9%) had a history of antibiotic/antimicrobial treatment be-
fore arriving to the hospital (Table 1). Drugs that were commonly used were ceftriaxone (n=173, 46.2%), 
metronidazole (n=147, 39.4%), cloxacillin (n=64, 17.1%), ciprofloxacin (n=25, 6.6%) and co-trimoxazole 
(n=21, 5.5%).  
 Generally, there was high antimicrobial resistance in bacterial isolates in this study; Proteus spp, 
Klebsiella spp, and E.coli exhibited relatively high resistance to all drugs tested among Gram-negative iso-
lates. Ampicillin resistance was frequent among Klebsiella spp (n=24, 92.3%), Proteus spp (n=21, 75%), and 
E. coli (n=13, 68.4%). Other bacterial spp such as Enterobacter cloacae, Acinetobacter baumannii, Serratia 
spp, Morganella morganii and Providentia spp were resistant by 100% to ampicillin.  Resistance of Proteus 
spp, Klebsiella spp and E.coli to cefazolin was (n=23, 82.1%), (n=16, 61.5%), and (n=11, 57.9%) respectively 
with all other spp at 100% resistance. Resistance to third generation cephalosporins (ceftriaxone and 
ceftazidime) was as well observed for Klebsiella spp (n=14, 53.8% and n=12, 46.2%) and E. coli (n=8, 42.1% 
and n=7, 36.8%). Table 5a.  Among the Gram-positive isolates, S. aureus was the only species, which 
demonstrated detectable resistance to penicillin (n=22, 100%), erythromycin (n=11, 50%), trime-
thoprim/sulpha (n=10, 45.5%), as well as cefoxitin (n=6, 27.3%). All S. aureus in this study were sensitive to 
vancomycin. Refer to table 5b. Table 5c summarizes the susceptibility pattern of the six cefoxitin-resistant 
S. aureus and 16 cefoxitin-susceptible S. aureus. Resistance of cefoxitin-resistant S. aureus to other drugs 
such as erythromycin, penicillin and trimethoprim sulpha was 100%, while none were resistant to 
vancomycin and chloramphenicol. All cefoxitin-susceptible S. aureus isolates were resistant to penicillin 
(100%), 6 (37.5%) to erythromycin, 5 (31.3%) to trimethoprim sulpha and 1 (6.3%) to chloramphenicol.  
None were resistant to vancomycin. 
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Discussion 
Culture results 
KCMC is a referral hospital serving approximately 11 million people in the northern zone of Tanzania. We 
conducted a two-year study from August 2013 to August 2015 to determine the pattern of bacterial patho-
gens associated with different health conditions among patients who were admitted at medical and surgi-
cal departments in this hospital.  
 The culture results revealed a higher positive growth rate on wound swab specimens (n=180, 72.3%), 
compared to others. Both Gram-negative and positive species were observed. Our findings are in agree-
ment with other studies in Africa where wound infections tend to manifest with a variety of bacterial path-
ogens 24,25. This is explained by the complexity of wound specimens that will tend to have a variety of bac-
terial pathogens, depending on the way wounds were acquired. Wounds acquired from a community envi-
ronment will have more diverse organisms than hospital-acquired wounds 26,27. In our study there were few 
positive blood specimens  (n=15, 6%) on culture, a finding which is in agreement with other studies that 
showed a low positive growth of blood cultures 28. Possibly this is because most septicemia cases we tested 
were not due to bacterial infections, a finding that has been reported from other studies in Tanzania29. The 
use of antibiotic prior to coming to the hospital, which hinders the detection of susceptible organisms30, 
may be another reason. This is a practice which is very common in Tanzania and other developing countries 
31–33. KCMC being a tertiary care hospital receives patients referred from health facilities in Kilimanjaro re-
gion and other parts of Tanzania. The majority of these patients have been treated with antibiotics in the 
referring hospital. However, the patients could also have self-medicated since antibiotics are easily availa-
ble and policies to control improper use of antibiotics are non-existent in Tanzania, as in other developing 
countries 31,33–36. 
 
Bacterial spectrum 
The bacterial spectrum observed from this study showed a high diversity of Gram-negative bacilli such as 
Proteus spp (12.7%), E.coli (11.7%), Pseudomonas spp (10.6%) and Klebsiella spp (10.1%), with Staphylococ-
cus aureus (9.3%) being the predominant Gram-positive isolate. The majority of these Gram-negative bacilli 
were from wound infections rather than from other disease conditions. This predominantly Gram-negative 
infection pattern, as also observed in other studies,25,37,38 is different from that most commonly reported 
from Western Europe and North America39,40. The reasons for this are not entirely known, but recent stud-
ies have also shown that higher temperatures are correlated with increased numbers of infections caused 
by Gram-negative bacterial species 41. Our results do however emphasize that we cannot use knowledge 
obtained in Western Europe and North America directly for clinical care and empirical treatment in Sub-
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Saharan Africa. 
 
Infection pattern 
Like any other resource-constrained countries, Tanzania is still experiencing the burden of infectious dis-
eases. In the current study we observed presence of wound infections (n=263, 45.9%), septicemia (n=46, 
8.03%), diarrhoea (n=20, 3.5%), HIV (n=81, 14.1%), and tuberculosis (n=60, 10.5%) and many other respira-
tory infections. As also indicated in other studies 14,42 , these diseases are still health challenges in low-
income countries. We also recognized the presence of non-communicable diseases such as cancer (n=52, 
9.1%) and diabetes (n=122, 21.3%). This suggests co-existence of communicable and non-communicable 
diseases in low-income countries as has been indicated in other studies 43,44. The increase of diabetes in 
Tanzania may be the effect of little knowledge about the risk factors associated with the disease4, which 
may be related to the majority (n=339, 59.2%) of the participants having only primary level education. 
There was no relationship between the most frequently isolated bacteria and conditions like diabetes and 
cancer. However, a non-statistically significant association between diabetes and Proteus spp (19%) and E. 
coli (14%) (P=0.07) was observed. The finding was more or less the same with HIV status. It was noted that 
prevalence of Proteus spp (16%), and Pseudomonas spp (13%) were higher in wound infections than in 
those with no wound infection (9% and 6%, respectively), and the difference was statistically significant (P 
=00.3). This is in agreement with other studies26 despite the fact that the design of the studies was differ-
ent. Again we can generally attest that aetiology of a wound infection is broad, depending on environment 
and nature of the wound. 
 
Antimicrobial susceptibility testing 
Proper identification and determination of antimicrobial resistance of the bacterial pathogens is crucial in 
order to help physicians to provide proper treatment promptly. The advancement in pharmaceutical indus-
tries has lead to discoveries of many antibiotics, which has facilitated physicians’ efforts into providing 
quality effective medical care. Despite of this increase, prudent use is essential in controlling antimicrobial 
resistance, which has now become one of the major challenges for medical progress. The current study 
demonstrated that a majority (n=412, 71.9%) of patients had sought treatment prior to coming to the hos-
pital. It is likely these patients received antibiotics during their previous treatment. The most frequently 
used drugs were ceftriaxone (46.2%), metronidazole (39.4%), cloxacillin (17.1%), ciprofloxacin (6.6%) and 
co-trimoxazole (5.5%). Along with this, the observed resistance patterns of Gram negative bacterial isolates 
tested on drugs such as amoxicillin, ampicillin, gentamicin, trimethoprim sulpha and chloramphenicol was 
relatively high in ampicillin (82.4%) and trimethoprim-sulpha (60%), and below 50% in the rest. This is 
probably due to the fact that these drugs are used in Tanzania as first-line antibiotics in treatment of gas-
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trointestinal diseases, respiratory diseases, obstetrical/gynaecological, cardiovascular and nervous system 
diseases 45.  Their easy availability from hospitals causes these drugs to be commonly used for treatment by 
medical practitioners as well as for self-medication, factors which play a great role in drug resistance 34,35,46. 
The finding is in agreement with other two studies in Tanzania which indicated resistance of E.coli and 
Klebsiella to trimethoprim-sulfamethoxazole, ampicillin, amoxicillin-clavulanic acid and gentamicin (100%, 
96%, 88%, 60%) and (85%, 95%, 70%, 70%) respectively 47,48. Resistance ranging from 9.1% to 78% also has 
been noted to ciprofloxacin and nalidixic acid. These are categorized as second line drugs in Tanzania yet 
they show a high frequency of resistance. As ceftriaxone is a third-generation cephalosporin, we expected 
its use to be controlled, yet it was the most used.  Moreover, convincing percentages of resistant strains of 
E. coli and Klebsiella to first and third-generations of cephalosporins have been broadly noted, ranging from 
36.8 to 61.5%. This finding suggests existence of extended spectrum beta lactamase  (ESBL) bacteria, as has 
been addressed in other studies in Tanzania49 where  64.3% of E. coli and 80% of Klebsiella pneumoniae 
were ESBL producers. The presence of ESBL producers reduces treatment options, resulting in higher mor-
bidity and mortality due to severe infections and sepsis. 
 S. aureus was the predominant spp among Gram-positive isolates. It accounted for 6 (27.3%) of the ob-
served resistances to cefoxitin and other antibiotics such as erythromycin, trimethoprim and penicillin G, a 
characteristic that we would postulate to indicate methicillin-resistant Staphylococcus (MRSA) clones, as 
has been suggested in other studies50.  
 
Conclusion  
The study has revealed a wide range of causative agents, with an alarming rate of resistance to the com-
monly used antimicrobial agents. Furthermore, the bacterial spectrum differs from those observed in high-
income countries. This highlights the imperative of regular generation of data on aetiological agents and 
their antimicrobial susceptibility patterns especially in infectious disease endemic settings. The key steps 
would be to ensure the diagnostic capacity at a sufficient number of sites and routine exchange, compari-
son, analysis and reporting of data. As the minimum, sentinel sites (hospitals) across the country and region 
should report on a representative subset of bacterial species and their susceptibility to drugs at least once a 
year. A central organizing body should collate the data and report to all relevant national and international 
stakeholders. 51 
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Table 1 
 
  
Socio-demographics and clinical characteristics of the study participants admitted at 
KCMC (n=575)                                                                                                                        
n (%) 
Median age in years (IQR) 43   (30-57)
 
 
Male gender 348 (61%) 
Female gender  227 (39%) 
Department   
  Surgical ward  232 (40.5) 
  Medical ward 277 (48.3) 
  ICU 49   (8.6) 
  Paediatric 15   (2.6) 
Occupation   
  Farming 271 (47.3) 
  Employed 56   (9.8) 
  Business 121 (20.7) 
  Other 132 (21.8) 
Education  
  None 130 (22.7) 
  Primary 339 (59.2) 
  Secondary 70   (12.2) 
  Tertiary 34    (5.9) 
Marital  
  Single 179  (31.2) 
  Married 325  (56.7) 
  
*
Widowed  69   (12) 
Disease conditions   
  *Wound  263 (45.9) 
  Pneumonia  87   (14.4) 
  Tuberculosis 64   (10.6) 
  Septicemia  52   (8.6) 
  Diarrhea 21(3.5) 
  Meningitis 4(0.7) 
Comorbidities   
  Diabetes  122 (21.3) 
  HIV  81  (14.1) 
  Cancer  52 (9.1%) 
Treatment prior to admission  
 
  Yes 412 (71.9%) 
IQR (Interquartile range) ICU, intensive care unit TB, Tuberculosis HIV, Human Immunodeficiency Virus 
* Widowed: widowed and divorced, Gender n=574, age n=559, the rest n=573, 2 patients had no informa-
tion, *wound (includes abscess) 
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Table 1 summarizes bacterial pathogens identified in this study. Where more than one subtypes identified, collectively they were 
named as species (spp) of that genus in order to accommodate all groups of bacteria in a single table. 
 
 
 
 
 
 
 
 
                                                                    Specimen N (%) 
Isolates Total (N) Wound swab Sputum Stool                   Blood 
Gram neg rods 61 52 (85.2) 6  (9.8) 2  (3.3) 1  (1.6) 
Proteus spp 48 44 (91.7) 0  (0) 2  (4.2) 2  (4.2) 
Escherichia spp 44 24 (54.5) 5  (11.4) 11 (25) 4  (9.1) 
Pseudomonas spp 40 37 (92.5) 3  (7.5) 0  (0) 0  (0) 
Klebsiella spp 38 28 (73) 7  (18.4) 3  (7.9) 0  (0) 
Staphylococcus aureus 35 29 (82.9) 2  (5.7) 0  (0) 4 (11.4) 
CoN Staphylococcus 25 18 (72) 2  (8) 2  (8) 3  (12) 
Unknown 22 17 (77.3) 4  (18.2) 1  (4.5) 0  (0) 
Streptococcus spp 17 7  (41.2) 9  (52.9) 0  (0) 1  (5.9) 
Enterobacter spp 15 12 (80) 2  (13.3) 1  (6.7) 0  (0) 
Bacillus spp 8 7  (87.5) 0  (0) 0  (0) 1  (0) 
Acinetobacter spp 5 3  (60) 2  (40) 0  (0) 0  (0) 
Serratia spp 4 2  (50) 1  (25) 1  (25) 0  (0) 
Providentia spp 4 4  (100) 0  (0) 0  (0) 0  (0) 
Enterococcus spp 3 3 (100) 0  (0) 0  (0) 0  (0) 
Gram positive cocci 2 1  (50) 1  (50) 0  (0) 0  (0) 
Dipthroids spp 2 1  (50) 1  (50) 0  (0) 0  (0) 
Stenotrophomonas spp 1 1  (100) 0  (0) 0  (0) 0  (0) 
Morganella spp 1 1  (100) 0  (0) 0  (0) 0  (0) 
Cytrobacter spp 1 1  (100) 0  (0) 0  (0) 0  (0) 
Aeromonas spp 1 1  (100) 0  (0) 0  (0) 0  (0) 
 
Total 
 
377 
 
293 (77.7) 
 
45 (11.9) 
 
23 (6.1) 
 
16 (4.2) 
Table 2 
   Bacteria isolates obtained from culture positive specimens  
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Table 3 
 
Health conditions and commonly isolated bacterial species 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Health condition S.aureus, n (%) Klebsiella spp, n (%) Proteus spp, n (%) E.coli, n (%) Pseudomonas spp, n (%) 
Burn wound 6 (17.1) 6(14.6) 10(20.4) 2(4.5) 8(20) 
Motor traffic wound 3 (8.6) 1(2.4) 6(12.2) 1(2.3) 1(2.5) 
Post surgical wound 2 (5.7) 6(14.6) 2(4.1) 3(6.8) 2(5) 
Diabetic wound 5 (14.3) 7(17.1) 15(30.6) 8(18.2) 8(20) 
Septic wound 20 (57.1) 21(51.2) 37(75.5) 24(54.5) 31(77.5) 
a 
Other wound 11(31.4) 6(14.6) 13(26.5) 9(20.5) 17(42.5) 
Diarrhea 1 (2.9) 1(2.4) 1(2) 5(11.4) 0(0) 
Pneumonia 1 (2.9) 3(7.3) 0(0) 4(9.1) 0(0) 
Septicemia 0 (0) 2(4.9) 3(6.1) 1(2.3) 2(5) 
Malaria 1 (2.9) 0(0) 1(2) 0(0) 1(2.5) 
Cancer 4 (11.4) 4(9.8) 2(4.1) 4(9.1) 5(12.5) 
Diabetes 9 (25.7) 10(24.4) 18(36.7) 13(29.5) 8(20) 
HIV 3 (8.6) 4(9.8) 3(6.1) 6(13.6) 1(2.5) 
TB 1 (2.9) 1(2.4) 0(0) 3(6.8) 1(2.5) 
a 
wound due to animal bite,  gunshot 
TB tuberculosis 
HIV-Human Immunodeficiency Virus 
NB: Percentages were obtained by cross tabulation of each comorbidity and isolate 
S.aureus N=35, Klebsiella spp N=41, Proteus spp N=49, E.coli N=44, Pseudomonas spp N=40 
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            Table 4 
A. Commonly isolated bacteria and disease comorbidity status 
 
 
Bacterial  
Isolates 
                   Diabetes     P 
Value 
                         HIV     P 
Value 
             Cancer    P 
Value 
         No       Yes      No     Yes             No        Yes   
Proteus spp 0.11 (0.85 - 0.92) 0.19 (0.12 - 0.28) 0.07 0.13 (0.10 - 0.17)  0.10 (0.03 - 0.26) 0.53 0 .14 (0.10 - 0.18)  0.06 (0.02 - 0.22)  0.10 
E.coli 0.11 (0.08 - 0.15) 0.14 (0.08 - 0.22) 0.50 0.11 (0.08 - 0.15)  0.19 (0.09 - 0.37)  0.26 0.12 (0.09 - 0.15)  0.12 (0.05 - 0.29)  0.93 
Klebsiella spp 0.11 (0.07 - 0.15) 0.11 (0.06 - 0.18)  0.89 0.11 (0.08 - 0.14)  0.13 (0.05 - 0.30) 0.73 0.11 (0.08 - 0.15)  0.12 (0.05 - 0.29)  0.82 
S.aureus 0.09 (0.06 - 0.13)  0.09 (0.05 - 0.17)  0.94 0.09 (0.07 - 0.13)  0.10 (0.03 - 0.27)  0.94 0.09 (0.06 - 0.13) 0.12 (0.05 - 0.29) 0.60 
Pseudomonas 
spp  
0.11 (0.08 - 0.16) 0.08 (0.04 - 0.16) 0.39 0.11 (0.08 - 0.15)  0.03 (0.00 - 0.20)  0.03 0.10 (0.07 - 0.14)  0.15 (0.06 - 0.32) 0.45 
 
                                      B. Commonly isolated bacteria and wound infections status 
Bacterial iso-
lates 
              
                 Wound infection 
 
P-value 
      
 
 
              
            No 
          
            Yes 
       
Proteus spp 0.09 (0.05 - 0.14) 0.16 (0.12 - 0.21) 0.03       
E.coli 0.14 (0.08 - 0.15) 0.10 (0.07 - 0.15) 0.26       
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Klebsiella spp 0.14 (0.09 - 0.21) 0.09 (0.06 - 0.13) 0.13       
S.aureus 0.11 (0.06 - 0.17)  0.08 (0.06 - 0.13)  0.50       
Pseudomonas 
spp 
0.06 (0.03 - 0.12) 0.13 (0.09 - 0.18) 0.03       
 
 Table 4a summarizes the association between commonly isolated groups of bacteria and absence or presence of three health conditions Diabetes, HIV and Cancer as common co-
morbidities identified in patients participated in this study. While table 4b summarizes association between common bacteria isolates and presence or absence of wound infection 
since most of the patients were diagnosed to have wound infections.  
NB:  Numbers described as; Proportion (95% Confidence interval). 
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Table 5 
 
Antimicrobial resistance* pattern of bacterial isolated from patients admitted at KCMC tertiary care hospital (N=130) 
 
 A: Gram-negative bacterial isolates (n=106) 
  AM CZ SXT NA C CRO CAZ AMC CIP GM 
Organisms N R (%) R (%) R (%) R (%) R (%) R (%) R (%) R (%) R (%) R (%) 
Proteus spp 28 21(75) 23(82.1) 18(64.) 22(78.6) 19(67.9) 15(53.6) 12(42.9) 4(14.3) 11(39.3) 8(28.6) 
Klebsiella spp 26 24(92.3) 16(61.5) 18(69.2) 12(46.2) 6(23.1) 14(53.8) 12(46.2) 15(57.7) 11(43.2) 10(38.5) 
Pseudomonas spp 22  ND  DN  ND ND  14(66.7)  ND 4(18.2)  ND 2(9.1) 3(13.6) 
E.coli   19 13(68.4) 11(57.9) 12(63.2) 10(52.6) 3(15.8) 8(42.1) 7(36.8) 8(42.1) 9(47.4) 7(36.8) 
E.cloacae 5 5(100) 5(100) 2(40) 2(40) 2(40) 4(80) 3(60) 5(100) 2(40) 3(60) 
A.baumanii 3 3(100) 3(100) 1(33.3) 2(66.7) 2(66.7) 3(100) 2(66.7) 3(100) 1(33.3) 1(33.3) 
Serratia spp 2 2(100) 2(100) 0 0 0 0 0 2(100) 0 0 
Morganella morganii 1 1(100) 1(100) 0 0 0 0 0 1(100) 0 0 
Providentia spp 1 1(100) 1(100) 0 0 1(100) 0 0 1(100) 0 0 
Total 106 70(82.4) 62(72.9) 51(60) 48(56.5) 47(44.3) 44(51.8) 40(37.4) 39(45.9) 36(33.6) 32(29.9) 
                        
     B. Gram positive bacteria  (n=24)  
    P E SXT CTX C VA         
Organisms N R (%) R (%) R (%) R (%) R (%) R (%)         
S.aureus 22 22(100) 11(50) 10(45.5) 6(27.3) 1(4.5) 0(0)         
S.pneumoniae 2 1(50) 1(50) 1(50) 0(0) 0(0) ND         
Total 24 23/24(95.8) 12/24(50) 11/24(45.8) 6/24(25) 1/24(4.2) 0(0)         
            
            
            
       
C: Susceptibility pattern of CXT resistant and CXT sensitive S.aureus to other drugs (N=22) 
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CTX 
 
C 
 
E  
 
P 
 
SXT 
 
VA 
    
 
 
Organism  
 
N 
 
R (%) 
 
R (%) 
 
R (%) 
 
R (%) 
 
R (%) 
 
R (%) 
    
CXT resistant 
S.aureus  
6 6 (100) 0 (0) 6 (100) 6 (100) 6 (100) 0 (0)     
CXT susceptible 
S.aureus  
16 0 (0) 1 (6.3) 6 (37.5) 16 (100) 5 (31.3) 0 (0)     
AMC:  Amoxicillin-Clavilunic acid, AM: Ampicillin, CZ: Cefazoline, CAZ: Ceftazidime, CRO: Ceftriaxone, C: Chloramphenical, CIP: Ciprofloxacin, GM: Gentamycin, NA: Nalidixic acid, 
SXT: Trimeth/sulpha. ND =not determined, CXT: Cefoxitin, E: Erythromycin, P: Penicillin G, VA: Vancomycin, *Resistance represent intermediate and resistance       ND =not determined      
N= Total number tested, 0= No resistance. 
 
NB: Part C of the table shows susceptibility pattern of the six cefoxitin resistant S.aureus (probably MRSA) and sixteen cefoxitin susceptible S.aureus  
 
